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The objective of this study was to evaluate the eﬀect of storage under various conditions on the concentrations of major bovine
acute phase protein—serum amyloid A, and its mammary isoform. Blood samples were taken from seven clinically healthy calves,
and milk samples from six clinically healthy dairy cows. The harvested blood serum and the milk samples were fractioned into
aliquots. One aliquot was analyzed on the day of collection without storage. The second aliquots were stored at 4◦Cf o r1d a y ,
the remaining aliquots were kept frozen at −18◦C for 2, 7, 14, and 21 days, and then analyzed. Blood serum was analyzed for
serum amyloid A (SAA). The concentrations of mammary isoform of SAA (M-SAA) were measured in milk samples. Over time,
the concentrations of SAA in serum showed a tendency of signiﬁcant decrease during storage at −18◦C( P<0.01). Similarly, the
values of M-SAA decreased signiﬁcantly in samples maintained at freezer temperatures (P<0.001). In the refrigerated samples,
we found non-signiﬁcantly lower values of SAA, as well as M-SAA. Presented results indicate that the storage temperature and
duration may markedly aﬀect the concentrations of bovine SAA and M-SAA.
1.Introduction
Biochemical investigations have central function in clinical
chemistry with an important aid to provide principal bio-
chemical information for clinicians in the diagnosis, prog-
nosis, monitoring, and screening of diseases. It is widely
accepted that the majority of medical decisions are made
using laboratory data [1]. Such information will be of value
only if it is accurate and relevant and if its signiﬁcance is
appreciated by the clinician so that it can be used appropri-
ately to guide clinical decision-making [2]. The specimen for
analysis must be collected and transported to the laboratory
according to a speciﬁed procedure, and every step in the
process of sample handling and analysis requires careful
attention if the data are to be of clinical value [3]. In some
cases, the analysis is delayed, or the specimens are sent to
distant laboratories for analysis. Moreover, the planning for
multiple experimental time points often results in samples
that will be analyzed together at a later date and thus
subjected to diﬀerent periods of storage before analysis
[4]. In such cases, degradation of labile analytes must be
prevented by refrigerating or freezing the samples. A lot of
authors stated that not only physiological conditions and
factors (e.g., age, sex, pregnancy, and nutritional status)
but also inadequate biological sample storage, as a potential
source of preanalytical errors, may markedly aﬀect the con-
centrations of many biochemical variables [5–7]. However,
the inﬂuence of sample storage on the concentrations of
less frequently measured biochemical variables, including
acute phase proteins, and their stability during storage in
veterinary medicine is less well documented.
Acute phase proteins are a group of blood proteins that
change in concentration in animals subjected to external or
internalstimulisuchastissueinjury,inﬂammation,impaired
homeostasis, trauma, or stress [8]. In cattle, serum amyloid
A (SAA) is one of the diagnostically most important acute
phase proteins with an increase in serum concentrations up
to 1000 times, as a result of inﬂammatory response [9].
Serum amyloid A is a small hydrophobic protein that is2 Veterinary Medicine International
the precursor of amyloid A protein, the major protein of
α-amyloid, so it is potentially involved in the pathogenesis
of reactive amyloidosis [10]. Several isotypes of SAA were
found. Of these, isotypes SAA1 and SAA2 respond to
inﬂammatorystimuliwithmarkedlyincreasedproductionin
the liver [11]. The SAA3 isoform is expressed in nonhepatic
tissues during the acute phase response with increases found
in lung or mammary gland [12]. The role of mammary-
associated isoform of SAA (M-SAA) is related to new-
born adaptation to extrauterine life and mammary tissue
remodeling in cows with mastitis [13]. Acute phase proteins
have been used as biomarkers of diseases for decades in
human medicine [14]. However, although the measurement
of the concentrations of acute phase proteins can detect
or conﬁrm the presence of infection or pathological lesion
and it provides useful information for the monitoring of
the health status of animals, acute phase proteins have been
relatively underutilised in the veterinary medicine. The use
of serum amyloid A has been limited due to diﬃculties
in puriﬁcation and quantiﬁcation, probably because it is
a hydrophobic apolipoprotein that is complexed within
serum high-density lipoproteins [15]. In bovine practice, an
increased focus on the application of acute phase proteins,
including serum amyloid A, has recently been developed.
Stability and storage study is one of the most important
studies that should be performed during the course of the
introduction of the method of the acute phase protein
determination.
For this reason, the aim of the present study was to
evaluate the eﬀect of storage under various conditions on the
concentrations of major bovine acute phase protein-serum
amyloid A (SAA) in serum samples of calves. Additionally,
the stability of mammary isoform of SAA in milk samples
from dairy cows during storage was investigated.
2.MaterialandMethods
2.1. Sample Collection. The eﬀect of storage at freezer and
refrigerator temperatures on the concentrations of serum
amyloid A during storage was investigated in blood samples
from seven clinically healthy female calves from a conven-
tional dairy farm. The calves were of a Slovak spotted breed
and its crossbreeds at the age of 4–6 months, and their
body weight was 85–140kg. The evaluated animals were
housed loosely in larger groups and fed hay and grain with
free access to water. Blood samples for the analyses were
collected by direct puncture of v. jugularis into serum gel
separator tubes without anticoagulant. Blood samples were
allowed to clot at room temperature and then centrifuged
at 3000g for 30 minutes to separate serum. The harvested
blood serum was fractioned into aliquots. One aliquot was
analyzed for the concentrations of serum amyloid A (SAA,
μg/mL) immediately after the separation without storage,
and these results obtained at time 0 were considered as initial
concentrations. The second aliquot of the separated serum
was stored in refrigerator at 4◦Cf o r1d a ya n dt h e na n a l y z e d .
The remaining aliquots were kept frozen at −18◦C, and the
concentrations of SAA were determined after 2, 7, 14, and 21
days of storage.
For the evaluation of the changes in the concentrations
of mammary isoform of SAA (M-SAA, ng/mL) during
storage, milk samples from six clinically healthy dairy cows
from a conventional dairy farm were included into this
study. The cows were of the Slovak spotted breed and its
crossbreeds of 3–5 years of age. The evaluated cows were
fed twice a day individual feeding rations according to
the milk production and had ad libitum access to water.
Composite milk samples were collected into plastic tubes
by hand-stripping. Forestrips were milked out, and then
approximately equal parts of milk from each quarter were
taken and mixed together. The collected milk samples were
fractioned into aliquots. One aliquot was analyzed for the
concentrations of M-SAA on the day of sample collection
without storage. The second aliquot of milk samples was
stored in refrigerator at 4◦C for 1 day and then analyzed. The
remaining aliquots were stored at −18◦C and were analyzed
for M-SAA concentrations after 2, 7, 14, and 21 days of
storage.
2.2. Laboratory Analyses. The serum concentrations of SAA
were analyzed by method of sandwich enzyme-linked
immunosorbent assay using commercial ELISA kits (Tridelta
Development, Ireland) according to the procedure described
by the manufacturer. All the samples, including the stan-
dards, were tested in duplicate. The optical densities were
read on automatic microplate reader Opsys MR (Dynex
Technologies, USA) at 450nm using 630nm as reference.
The concentrations of M-SAA were determined by
ELISA method using commercial diagnostic kits (Tridelta
Development, Ireland) according to the method described
forSAA,modiﬁedbythemanufacturerforthedetermination
of M-SAA in milk samples.
2.3. Statistical Analyses. Arithmetic means (x), standard
deviations (SD), and medians for the concentrations of SAA
in serum, as well as milk samples, were calculated using
descriptive statistical procedures. The eﬀect of time on the
concentrations of evaluated variables during the storage of
the samples frozen at −18◦C was evaluated by repeated
measuresANOVAtestwiththeTukey-Kramermultiplecom-
parisons test to determine which means diﬀer signiﬁcantly
from one other. The paired t-test was used for the evaluation
of the diﬀerences between the initial concentrations of
measured parameters and the values quantiﬁed in samples
stored 1 day at 4◦C. All statistical analyses were performed
using the programme GraphPad Prism V5.02 (GraphPad
Software Inc., California, USA).
3. Results
The data referring to the concentrations of SAA in bovine
serum, and the values of M-SAA in milk samples during
storage expressed as average values, standard deviations, and
medians, including the signiﬁcance of diﬀerences between
the mean concentrations, are presented in Tables 1 and 2.
TheevaluationofthemeanserumconcentrationsofSAA
over time showed a tendency of signiﬁcant decrease of values
during storage at −18◦C( P<0.01, Table 1). The samplesVeterinary Medicine International 3
Table 1: The changes in the concentrations of SAA and M-SAA with time during freezer storage.
Time of analysis (days) P
Parameter 0 2 7 14 21
SAA (μg/mL)
x 30.30a,A 17.89b 17.42b 13.77B 13.94B <0.01
± SD 17.19 12.32 10.10 10.94 12.07
median 30.50 15.60 17.10 12.00 17.30
M-SAA (ng/mL)
x 5945.06A,x 4822.77B 4261.17y 4162.26y 4149.15y <0.001
± SD 1765.70 1819.70 1559.00 1641.60 1532.60
median 6439.60 5471.70 4631.20 4685.90 4483.20
P: signiﬁcance of ANOVA test.
Means with diﬀerent superscripts in rows diﬀer signiﬁcantly at: a,bP<0.05; A,BP<0.01; x,yP<0.001.
Table 2: Comparison of the concentrations of SAA and M-SAA
analyzed in samples without storage and in samples stored at 4◦C
for 1 day.
Samples
P
Parameter Without storage Stored at 4◦C
for 1 day
SAA (μg/mL)
x 30.30 26.24
n. s. ±SD 17.19 14.97
Median 30.50 30.80
M-SAA
(ng/mL)
x 5945.06 5376.91
n. s. ±SD 1765.70 5376.91
Median 6439.60 5906.90
P: signiﬁcance of paired t-test.
stored in a freezer had signiﬁcantly reduced concentrations
from day 2 onwards (P<0.05), with the signiﬁcantly
lowestconcentrationsondays14and21ofstoragecompared
with the initial values (P<0.01). More detailed analysis
of the serum SAA concentrations showed that 50% of the
results of samples without storage (day 0) ranged from 11.70
to 42.10μg/mL, with median concentration of 30.50μg/mL
(Figure 1). The median SAA concentration recorded on day
2 of storage was about half as lower (15.60μg/mL) than the
initial value, and 50% of measured values were in the range
of6.89–29.70μg/mL.Similartrendoflowervalueswasfound
in the next period of freezer storage, with the lowest median
concentration of SAA on day 14 of storage (12.00μg/mL).
The changes in the mean concentrations of M-SAA in
milk samples in relation to the time of storage at the tem-
perature of −18◦C were highly signiﬁcant (P<0.001,
Table 1). For the concentrations of M-SAA in milk samples
determined on day 2 of freezer storage, a signiﬁcant decrease
of values was found (P<0.01, Table 1), with further
signiﬁcant decrease of concentrations after day 7 of storage
compared with initial values (P<0.001), and then the
values remained relatively stable for the evaluated period
of freezer storage. In the median concentrations of M-SAA
we observed a gradual decrease of values during freezer
storage, with the lowest median concentration determined
on day 21 of storage (4483.20ng/mL, Figure 2). By more
detailed evaluation of individual M-SAA concentrations we
found that during the initial analysis of milk samples 50%
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Figure 1: Concentrations of SAA in serum samples during freezer
storage.Theplotsshowthemedian(linewithinbox),25thand75th
percentiles (box), and minimum and maximum values (whiskers).
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Figure 2: Concentrations of M-SAA in milk samples during freezer
storage.Theplotsshowthemedian(linewithinbox),25thand75th
percentiles (box), and minimum and maximum values (whiskers).
of measured values ranged from 3936 to 7326ng/mL, and in
samples analyzed on day 2 of storage we already recorded
lower concentrations with the range of 50% of measured
values between 3371 and 6091ng/mL.4 Veterinary Medicine International
The mean concentration of SAA obtained in bovine
serumstoredat4 ◦Cfor1daywasnonsigniﬁcantlylowerthan
the value recorded by the evaluation of samples analyzed
immediately (Table 2). Similarly, when analyzing the con-
centrations of M-SAA in milk samples after the storage in
refrigerator, no signiﬁcant diﬀerences were found between
the concentrations determined in samples without storage
a n di nm i l ks t o r e d1d a ya t4 ◦C.
4. Discussion
Many clinical trials and research studies depend on delayed
batch analyses of collected blood samples. To accomplish
these analyses, blood samples are separated by centrifuga-
tion, and the harvested serum or plasma is quickly frozen
[16]. At speciﬁc follow-up times, the samples are thawed and
analyzed as designated by the study protocol. The stability
of some routine clinical biochemistry parameters (total
proteins, albumin, lactate dehydrogenase, creatine kinase,
trace elements, and hormones) was tested in human and
in a range of animal species under diﬀerent laboratory
storage conditions [4, 5, 17]. These studies stated that the
temperature and the duration of the storage are impor-
tant factors, which may impact the results of biochemical
analyses. Data from such reports regarding the stability of
acute phase proteins and the inﬂuence of storage on their
concentrations in blood samples are rather scarce. Stability
and storage studies were performed to determine the eﬀect
of storage on the concentrations of C-reactive protein, as
the diagnostically most important acute phase protein in
humans [18, 19]. In fact, data on storage stability of acute
phaseproteinsandtheeﬀectofthetemperatureandduration
of storage on their concentrations in veterinary medicine
are still limited. Because acute phase protein determination
may become of importance in laboratory testing also in
cattle, for serum amyloid A and its mammary isoform (to
be measured correctly), a better understanding of their
biological variation and the eﬀect of preanalytical factors on
their concentrations is required.
In the present study, we observed a marked eﬀect of
sample storage at lower temperatures on the concentrations
of serum amyloid A, characterized by diﬀerent intensities
of changes in its concentrations at freezer or refrigerator
temperatures. In frozen serum samples, the results showed
a trend of signiﬁcantly decreasing SAA, as well as M-
SAA concentrations over time. Signiﬁcantly lower concen-
trations were found already after 2 days of storage. The
S A Ac o n c e n t r a t i o n sd e t e r m i n e di ns e r u ms a m p l e ss t o r e da t
refrigerator temperatures diﬀered nonsigniﬁcantly from the
values measured in samples without storage, but its mean
value was lower. Storage stability of SAA was investigated by
Hillstr¨ om et al. [20] in equine serum samples. The authors
observed no signiﬁcant changes in SAA concentrations over
time in serum samples stored at 4◦C, and the variance
between days was not higher than could be explained by
the imprecision of the method. Similarly, in another study,
where an equine SAA standard pool was stored at 4◦Co v e r
a period of up to two months, no signiﬁcant changes in SAA
concentrationswerenoted[21].Theseauthorsobservedonly
a slight ﬂuctuation in measured values that they explained
by the imprecision of the method. In addition, no inﬂuence
on the stability of human SAA and C-reactive protein was
foundforthesamplesthatwerestoredat −20◦Cfor2months
until actual measurement [22]. Solter et al. [23]a n dC e r´ on
et al. [24] reported that acute phase proteins, including
haptoglobin and C-reactive protein, are more stable than the
cellular components of blood, and assays can be performed
on frozen serum samples. Aziz et al. [18] indicated that
the eﬀect of diﬀerent specimen processing and storage
conditionsontheconcentrationsofacutephaseproteinsmay
vary depending on the assay conﬁguration and should be
validated at the beginning of any research project. According
to our ﬁndings, bovine SAA appears to be less stable during
storage at lower temperatures, predominantly at freezing.
Diminished concentrations of SAA at lower temperatures,
obtained in our study during freezer, as well as refrigerator
storage, may be related to the lability and degradation of
this protein resulting from the changes in its molecular
conﬁguration during storage. Another reason for variations
in the stability of SAA during storage could be its biological
behavior [20]. However, the aforementioned contradictory
data indicate that further investigations are needed to clarify
the possible inﬂuence of the temperature and duration of
storage on the concentrations of bovine serum amyloid A
and to explain the changes in its concentrations during
storage at lower temperatures.
The eﬀect of storage temperature and duration on the
concentrations of mammary isoform of SAA in milk samples
of dairy cows is less well documented. According to the man-
ufacturer data, milk samples collected for the determination
of M-SAA can be stored for up to 2 days at 4◦Co rs t o r e d
frozen at −20◦C for longer periods (Tridelta Development,
Ireland). However, to our knowledge, no published studies
have been reported on the eﬀect of sample storage on the
concentrations of M-SAA in relation to the temperature and
duration of storage. In the presented study, we observed
a trend of signiﬁcantly progressively decreasing values of
M-SAA during storage at freezer temperatures from day
2 onwards. Similarly, nonsigniﬁcantly diminished M-SAA
concentrations were found in milk samples maintained at
refrigerator temperatures. The aforementioned reduction
in the concentrations of M-SAA in milk samples after
storage might be caused by degradation of this mammary
isoform of SAA, as several factors have been found to aﬀect
milk components during storage at various temperatures
and time [25]. Woltersdorf et al. [26] reported that the
freezing process and the resulting time delay of the analysis
may result in physical changes in the sample, which may
aﬀect the concentration of the analytes in the sample. The
concentrations of acute phase proteins, including M-SAA
in milk, are quantiﬁed to get information for diagnostic
or monitoring purposes [27, 28]. This demands precise
measurement of acute phase protein concentrations and
analytical stability. According to the presented results, serum
and milk samples without freezer storage are recommended
for SAA analyses in cattle, including the determination
of the concentrations of its mammary associated isoform
because the protein degradation during storage at lowerVeterinary Medicine International 5
temperatures may cause alterations in their concentrations.
Seeing that published data on the long-term stability of SAA
and predominantly its mammary isoform during storage
undervariousconditionsarestilllimited,furtherstudiesmay
be helpful.
5. Conclusions
For analytical approaches proper sample processing and
handling is of great importance. Therefore, issues related to
the preanalytical factors of acute phase protein measurement
should be considered to avoid potential misclassiﬁcation
between sick and healthy animals. Our results indicate that
the temperature and duration of storage as a part of proper
sample handling are important factors also for some acute
phase protein analyses. The results presented in our study
s h o w e dm a r k e de ﬀect of sample storage, predominantly
at freezer temperatures, on the concentrations of bovine
serum amyloid A and its mammary associated isoform with
progressively signiﬁcant decreasing values over the evaluated
time.Thus,afterlongerlastingstorageatlowertemperatures,
the measurement of SAA, as well as M-SAA, in serum
or milk samples may not be accurate, potentially causing
erroneous interpretations. According to these results it seems
to be important to analyse the samples for the mentioned
parameters without storage in freezer.
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